2014 annual results
Download
CARMAT subscribes to a new contingent equity line with Kepler Cheuvreux
Download
CARMAT will benefit from the European SEED program that supports innovative therapy developers seeking reimbursement
Download
The patient who received a CARMAT bioprosthetic heart in Nantes on August 5, 2014 has been discharged home
Download
2015 financial agenda
Download
CARMAT secures its cash position by reaching milestone n°5 of its contract with Bpifrance, and receives €5.3m
Download
CARMAT wins the 2014 INPI Award in the "Patent" category
Download
2014 half-year results
Download
